Resistant Hypertension and Renal Denervation. Considerations on the Results of the Symplicity HTN-3 Trial

被引：1
|
作者：
Ruilope, Luis M. [1 ,2 ]
Arribas, Fernando [3 ]
机构：
[1] Hosp 12 Octubre, Inst Invest I 12, Unidad Hipertens, E-28041 Madrid, Spain
[2] Univ Autonoma Madrid, Dept Med Prevent & Salud Publ, Madrid, Spain
[3] Hosp 12 Octubre, Serv Cardiol, E-28041 Madrid, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2014年 / 67卷 / 11期
关键词：
EUROPEAN-SOCIETY; POSITION PAPER; RATIONALE; DESIGN;
D O I：
10.1016/j.rec.2014.06.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：881 / 882
页数：2
相关论文
共 50 条
  • [1] Renal denervation after the symplicity HTN-3 trial
    Warchol-Celinska, Ewa
    Januszewicz, Andrzej
    Prejbisz, Aleksander
    Kadziela, Jacek
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2014, 10 (02): : 75 - 77
  • [2] Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
    Kandzari, David E.
    Bhatt, Deepak L.
    Sobotka, Paul A.
    O'Neill, William W.
    Esler, Murray
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Massaro, Joseph M.
    Negoita, Manuela
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Straley, Craig
    Townsend, Raymond R.
    Bakris, George
    CLINICAL CARDIOLOGY, 2012, 35 (09) : 528 - 535
  • [3] Was there real denervation in the SYMPLICITY HTN-3 trial?
    Ruilope, Luis M.
    EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1699 - 1700
  • [4] Renal sympathetic denervation in the aftermath of Symplicity HTN-3
    Kjeldsen, Sverre E.
    Elmula, Fadl E. M. Fadl
    Persu, Alexandre
    Jin, Yu
    Staessen, Jan A.
    BLOOD PRESSURE, 2014, 23 (05) : 256 - 261
  • [5] Renal Denervation after Symplicity HTN-3: An Update
    Alexandre Persu
    Yu Jin
    Fadl Elmula Mohamed Fadl Elmula
    Lotte Jacobs
    Jean Renkin
    Sverre Kjeldsen
    Current Hypertension Reports, 2014, 16
  • [6] Renal Denervation after Symplicity HTN-3: An Update
    Persu, Alexandre
    Jin, Yu
    Elmula, Fadl Elmula Mohamed Fadl
    Jacobs, Lotte
    Renkin, Jean
    Kjeldsen, Sverre
    CURRENT HYPERTENSION REPORTS, 2014, 16 (08)
  • [7] Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial
    Kario, Kazuomi
    Bhatt, Deepak L.
    Kandzari, David E.
    Brar, Sandeep
    Flack, John M.
    Gilbert, Colleen
    Oparil, Suzanne
    Robbins, Mark
    Townsend, Raymond R.
    Bakris, George
    CIRCULATION JOURNAL, 2016, 80 (06) : 1404 - +
  • [8] 12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension The SYMPLICITY HTN-3 Trial
    Bakris, George L.
    Townsend, Raymond R.
    Flack, John M.
    Brar, Sandeep
    Cohen, Sidney A.
    D'Agostino, Ralph
    Kandzari, David E.
    Katzen, Barry T.
    Leon, Martin B.
    Mauri, Laura
    Negoita, Manuela
    O'Neill, William W.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (13) : 1314 - 1321
  • [9] Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    Hedner, Thomas
    BLOOD PRESSURE, 2014, 23 (03) : 135 - 137
  • [10] Renal denervation—a valid treatment option despite SYMPLICITY HTN-3
    Roland E. Schmieder
    Nature Reviews Cardiology, 2014, 11 : 638 - 638
12345